Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma.
Jung Hoon ShinJi Yun LeeGyeong-Won LeeWon Seog KimYong ParkYoung Rok DoDea Sik KimKi Hwan KimYoon Seok ChoiJa Min ByunJunshik HongInho KimSung Soo YoonYoungil KohPublished in: British journal of haematology (2023)